Advertisement

Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x100px
Organisation › Details

F2G Ltd.

F2G is a world-leading UK- and Austria-based biotech company (F2G Ltd and F2G Biotech GmbH) focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections. F2G has discovered and developed a completely new class of antifungal agents called the orotomides. The orotomides selectively target fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine biosynthesis pathway. This is a completely different mechanism from that of the currently marketed antifungal agents and gives the orotomides fungicidal activity against a broad range of rare and resistant fungal mold infections. Olorofim (formerly, F901318) is F2G’s leading candidate from this class and is in a Phase 2b open-label study focusing on rare and resistant invasive fungal infections such as aspergillosis (including azole-resistant strains), scedosporiosis (including lomentosporiosis). Olorofim has received orphan drug status from the European Medicines Agency for the treatment of invasive aspergillosis and invasive scedosporiosis. Olorofim has received orphan drug status from the US FDA for the treatment of coccidioidomycosis, lomentosporiosis/scedosporiosis, and invasive aspergillosis. Olorofim has been granted Qualified Infectious Disease Product (QIDP) designation Invasive for aspergillosis, invasive scedosporiosis, invasive lomentosporiosis, coccidioidomycosis, invasive disease due to Scopulariopsis species, and invasive fusariosis. *

 

Period Start 2012-09-06 existent
  Group F2G (Group)
Products Industry antimycotic
  Industry 2 F901318 (F2G Ltd)
Persons Person Lavino, Francesco Maria (F2G 202104– CEO before Nabriva Therapeutics + Merck (US) + Cubist Pharmaceuticals)
  Person 2 Vink, Patrick (Forbion 202007c– Operating Partner former COO of Cubist before Mylan + Sandoz)
     
Region Region Manchester, Greater Manchester
  Country United Kingdom (GB)
  Street Lankro Way
Eccles
  City M30 0LX Manchester
  Tel +44-161-785-1270
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: F2G Ltd.. (4/12/21). "Press Release: Francesco Maria Lavino Appointed Chief Executive Officer of F2G Ltd". Manchester & Vienna.
     
   
Record changed: 2022-08-04

Advertisement

Picture Wirtschaftsförderung Sachsen Life Sciences in Saxony 650x200px

More documents for F2G (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Start-up Center 650x300px




» top